Contact Venk Varadan
Title Co-founder & CEO


Nanowear is an A.I.-based remote diagnostics platform built on FDA-cleared cloth nanotechnology, which captures and transmits 85+ dimensions of clinical-grade biomarker data from basic skin contact. Nanowear’s first of-its-kind platform enables a radical leap forward in telemedicine by empowering physicians with quantified decision-making thereby improving outcomes without the need for physical visits

Nanowear’s flagship product SimpleSENSE, also FDA 510(k)-cleared, captures and transmits medical-grade lung function, lung volume / capacity, heart function and cardiac rhythm, blood pressure, and blood flow effectively replacing the stethoscope, blood pressure cuff, ECG and respiration machines. This all-in-one device is also a digital platform via A.I.-based scoring, which provides deep, accurate, continuous, time synchronous and simultaneous assessment of the heart, lungs and upper vascular system by evaluating 120million+ data points / patient / day.

Nanowear’s unique sensing technology coupled with first-of-its-kind multi-layer deep learning, clustering, autoencoders, and generative adversarial methods continue to enable new discoveries and insights on triage-able risk associated with short and long-term diagnostics, or diurnal physiological changes, patient behavioral changes, and non-compliance to post-surgical prescription, acute illness, chronic disease management and oncology treatment.

Company News

Nanowear Receives FDA 510(k) Platform Clearance to Implement Forthcoming AI-based Diagnostics in its Closed Loop Hospital-at-Home Network

DateSep 28, 2021
Nanowear, a leading hospital-at-home and remote diagnostic platform informed by proprietary cloth nanotechnology and AI, today announced that it received its third FDA 510(k) clearance and first software-only clearance as an end-to-end digital platform, illustrating unique capabilities available to enterprise customer channels across a broad spectrum of diagnostic and monitoring verticals.
Read More →

Nanowear announces commercial distribution partnership in A.I.-based post-surgical recovery monitoring

DateMay 11, 2021
Nanowear, the leading nanotechnology and A.I.-based remote diagnostic company, today announced a commercial distribution partnership with a world leading aesthetic and reconstructive surgical device-manufacturer, to enhance and optimize post-surgical recovery for both patients and surgeons. 
Read More →

Nanowear Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable Remote Diagnostic Monitoring Platform

DateNov 11, 2020
Nanowear, the leading connected-care and remote diagnostic platform, today announced it has received FDA Class II 510(k) clearance for a first-of-its-kind cloth-based diagnostic platform, SimpleSENSE.
Read More →